A&C, Your Global GMP Partner,
are cGMP manufacturers of custom excipients, process solutions, buffers and
active pharmaceutical ingredients. A&C has been servicing the Life Science
industry since 1966, with GMP manufacturing facilities in Ireland and Canada
and sales & distribution offices globally.
A&C prides itself on being known as a company that provides full transparency in the supply chain which is demonstrated through our EXCiPACT GMP & GDP certification. We also have been audited by Health Canada, hold a Drug Establishment License, and our manufacturing sites are FDA registered.
A&C understands the unique processes of individual manufacturers and continues to provide custom solutions to support specific manufacturing and quality objectives.
Learn more at www.acggp.com
AMSA Spa, Cosma Spa and Clarochem Spa are enterprises dedicated to production of APIs according to cGMP European and US standards. AMSA Spa is one of the plants of the CFM Group. With total 250 m3 capacity,pilot units,modern labs and finishing areas they excel for the accurate regulatory service to their clients. They are operation units, together with CFM Spa of the holding CFMgroup.
Part of the USD 500 million Aarti Group of Industries, Aarti Drugs Ltd (ADL) was established way back in in 1984.
Since its inception, the Company has established a strong presence in the Anti-diarrhea, Anti-inflammatory therapeutic groups. With its manufacturing facilities at Tarapur and Sarigam, the Company manufactures Vitamins, Anti-arthritis, Anti-fungal, Antibiotics, ACE inhibitors, besides its range in , anti-diabetic, anti-cholinergic, sedatives and anti-depressant drugs.
The API Division of AARTI INDUSTRIES LIMITED (AIL) has focused on Research, Manufacturing APIs and Advanced Intermediates for Active Pharmaceutical Ingredients (APIs) for the GENERIC companies of the world. AARTI also carries out Contract Research and Custom Synthesis for innovator companies around the world. The facilities are USFDA and EUGMP approved. The various APIs which we manufacture cater to a vast array of therapeutic categories namely anti-asthma, anti-cancer, anti-hypertension, opthalmology, CNS agents, skincare etc. R&D is a major thrust area and our R&D centre is capable of developing innovative processes of complex chemistry and engineering to suffice customer requirements.
Aastrid International is an ISO 9001:2015 - certified company and Government of India Recognised Star Export House, where we have offices in India, China, and the UAE. Aastrid has been exporting APIs, Intermediates, Pellets & Excipients to more than 45 countries in the world. Aastrid is a reliable and dependable partner in the supply Chain.
AbbVie Contract Manufacturing has a portfolio of state-of-the-art facilities, offering a broad range of capabilities in North America and Europe. For more than 30 years, AbbVie Contract Manufacturing has offered contract manufacturing services that spans biologics, potent, drug product, prefilled syringes, fermentation, as well as selling high quality
active pharmaceutical ingredients (APIs).
The Brazilian Pharmochemicals Manufacturers Association- abiquifi - is a private entity that congregates about 25 main manufacturers of APIs designated to the pharmaceutical industry. At this exhibition, in cooperation with FINEP-Financer of Studies and Projects bound to Brazilian Ministry of Science and Technology (institution in charge of stimulating the Brazilian technologic development) and APEX (institution created to stimulate the Brazilian exportations), abiquifi is represented by important companies of the pharmochemical/pharmaceutic industries, whose productions are manufactured with the requirements of GMP and according with the specifications of main International Pharmacopeias.
Shanghai Acebright Pharmaceuticals Group Co Ltd was founded in 1996. More than 12 GMP standard manufacturing sites located in China and India. Focus on a serial of Vitamin products, ARV APIs & intermediates, and oncology APIs & FPPs, etc. Integrated CDMO service partner from R&D to commercial manufacturing.
In the world of packaging, ACG is indisputably a recognized player offering its services to industries across the world. ACG takes pride in being an award-winning manufacturer of a range of high-quality barrier packaging films for the pharmaceutical, medical-device, healthcare, and food packaging sectors. ACG's diverse portfolio of packaging solutions includes pharmaceutical-grade & camera-inspected range of aluminium-based foils, specialty packaging films, high-barrier, anticounterfeiting and polymer films. All its equipment is US FDA, European Pharmacopoeia and CFDA regulation compliant.
At the innovation lab, led by highly accomplished and expert professionals from the packaging industry ACG has launched specialty films such as AlukblissTM and Brandshield. Both of which have received several global accolades for innovation. From simple aluminum-based packaging foils, to multilayered and anti-counterfeiting films, ACG offers exceptional service in packaging.
Specialist products include:
• Aluminium based packaging foils
o Aluminium cold form blister foils
o Aluminium lidding foils
o Child-resistant and senior-friendly blister foils
o Tropical blister foils
• High Barrier Packaging Films
o High barrier laminated films
o Ultra-high-barrier PVdC films
• Anti-counterfeit and brand-building packaging film
• Speciality Packaging Films
o Aluminium look – alike thermoforming packaging films
o Laminated films for suppositories
o Unit Dose packaging films
• Multilayer films
o Barrier films for deep cavity blister packs
o PVC/PVdC Films
Aché Laboratórios Farmacêuticos S.A. is a leading
pharmaceutical company ranked #1 in prescription generation in Brazil. With
more than 50 years in the market, Aché counts on out-licensing partnerships for
20 countries in the world and it has a portfolio of more than 326 brands in the RX, OTC, Dermocosmetic & Nutraceutical markets.The company continuously invests in the development of innovative products, counting on promising NCE's in clinical development and a variety of "me better" products, based on differentiated technology platforms.
ACME is a
leading manufacturer of Tablets, Capsules, Injectables, Oral Contraceptives
& Levothyroxine Tabs.
Our sites are approved by EU GMP, UK-MHRA, PICS, INVIMA, ANVISA, FDA Philippines, DAV Vietnam Ethiopia, Tanzania, WHO Geneva. Triggered: TGA Australia, Health Canada and US FDA by filing planned in Q1 2018.
CTD Dossiers for Licensing
Contract Manufacturing Services
Contract Development& Research
Asia: Nepal, Sri Lanka, Philippines, Vietnam, Cambodia, Laos, Thailand, Yemen, Myanmar
Africa: Ethiopia, Nigeria, Ghana, Tanzania, Kenya, Uganda, Zambia, Malawi, Nigeria, Sierra Leone, Madagascar, Angola, Zimbabwe, Mozambique, Cameroon, Senegal, South Sudan
North America: US & Canada (Filing planned in Q1 2018)
Europe: United Kingdom, Hungary
South America: Brazil, Colombia, Guatemala, Nicaragua, Paraguay, Uruguay, Chile, Costa Rica, Venezuela, Peru
CIS: Kazakhstan, Uzbekistan, Ukraine
Responsibility of product patents lies with the buyer of the country
For more details please visit our website: www.acmeformulation.com& www.immacule.in
ACS DOBFAR, a privately held Italian company founded in 1973, is a fully integrated manufacturer of Cephalosporin and Penicillin APIs as well as Finished Dosage Formulations. With production sites around the world regularly inspected by US FDA, it is a leading company among exporters to the US market.
ADL Bionatur Solutions is a holding company integrated by ADL BioPharma and Bionaturis. This new entity arises as a global bioscience corporate group, delivering cost-effective and suitable solutions in health, nutrition, cosmetics and chemicals. The synergy of the integrated companies' competitiveness with complementary strengths have allowed the group to become a major benchmark in biotech and pharmaceutical industries, both in terms of quality and innovation.We are engaged in research, development, manufacturing and commercialization of high-quality and innovative products with unique attributes, making us the perfect partner to meet the changing needs of the market.ADL Bionatur Solutions is listed on MAB Spain.
Protexin are dedicated to producing innovative research based products of the highest quality for animals and humans.
Our belief is that nature is an ideal source of effective healthcare solutions, and that applied research and understanding can harness these solutions to the benefit of both humans and animals. We also know that too much refining of natural elements can reduce their effectiveness. That's why all products that carry the Protexin name are developed under our guiding philosophy – science and nature in balance.
In practice this means that the natural healthcare and probiotic supplements we manufacture are extensively researched for safety and efficacy. We work closely with leading universities, hospitals and research centres around the world on a range of ongoing research programmes. We are always looking to improve our products, but never compromise on their natural basis.
Advanced Enzymes, is a research driven company, having global leadership in manufacturing Enzymes and Probiotics. With the strength of 47+ enzymes today, It is dedicated to offer eco-safe solutions for industries like Pharmaceuticals, Animal Nutrition, Food Processing, Textiles and Leather processing, Advanced Enzymes through its technical enzyme experts is able to create value, and provide solutions to its clients in 59+ countries globally. Some of our core products are Serratiopeptidase, Fungal Lactase, Nattokinase, Alpha Galactosidase and Saccharomyces Boulardi
Ajinomoto will have two businesses represented at CPhI: the Amino Science division and Ajinomoto Bio-Pharma Services. Ajinomoto Amino Sciences develops and manufactures high quality amino acids for the bio-pharmaceutical industry. The amino acids are produced under cGMP conditions with non-animal materials, and are unsurpassed in quality and purity. Ajinomoto Bio-Pharma Services is comprised of the recently unified Ajinomoto Althea and OmniChem organizations. Ajinomoto Bio-Pharma Services is a global and fully integrated CDMO for small and large molecules, providing comprehensive process development services, cGMP manufacturing and aseptic fill finish services, including ADCs/cytotoxics and oligonuceotides.
AlbyPharma, formerly known as Suir Pharma Ireland, is a well-established contract manufacturer with 40 years of experience supplying Europe and US market. It has the first oral FDA-Approved Beta-Lactam facility in Europe, Solid Dosage Form facility and Softgel manufacturing capability. All that backed with in-house R&D, Microlab and analytical services.
Alchem International Pvt. Ltd., Delhi India's premiere phyto-chemical manufacturing facility has a customer base spanning 30 countries with over 210 customers for Pharmaceutical, Nutraceutical and Cosmetic API's and extracts. Through innovation, creativity and teamwork Alchem have optimized processes associated with quality production, and invested in state of the art analytical equipments for quality assurance and quality control meeting the highest standards. Alchem has expanded its horizon by value addition through Biotechnology, semi-synthesis and ventured into formulation through their wholly owned subsidiary Alchem Phytoceuticals for niche products.
Alembic Pharmaceuticals Limited is one of the leading pharmaceutical companies in India with a consolidated turnover of over US$ 500 Million. Established in 1907, Alembic has expertise in synthetic chemistry, formulation development and solid oral dosage form manufacturing. It has a state-of-the-art R&D facility which focuses on API Process Developments & Process Chemistry, Generic formulation development, Novel Drug Delivery systems, and Bio Equivalence studies. Manufacturing facilities are approved by USFDA, EDQM, German FDA, TGA, KFDA, MHRA, TPD, MCC, COFEPRIS and ANVISA.
Alivira Animal Health is one of the largest global Animal Health company, manufacturing APIs & FDFs •A SEQUENT group company employing 1,000+ people globally •A global leader in Anthelmintic & NSAID segments •Largest manufacturing site with USFDA and EU CEP approvals having 1000MT/A capacity •Strong presence in US & EU market •Filed: USVMF-13, EDMF-25, CEP-11 •Dedicated API R&D setup with 8 laboratories & 122 scientists •Relationship with top 10 global animal health players •Compliant to global EHS regulations & registered with ECOVADIS and PSCI
Alkaloids Corporation is celebrating its 50th anniversary this year.
We are leading manufacturers of APIs and Standardized Botanical Extracts strictly as per cGMP guidelines.
Products : Phyto-pharmaceuticals (APIs) : Ajmaline, Artemether, Cimetropium bromide, Colchicine, Digoxin, Hyoscine Butylbromide, Noscapine, Noscapine Hydrochloride, Papaverine HCl, Reserpine, Scopolamine Hydrobromide,Scopolamine Methylbromide, Scopolamine Methylnitrate, Thiocolchicoside.
Phytochemicals : Andrographolide, Betulinic acid, Curcumin, 10-DAB, Forskolin, 5-hydroxytryptophan (5HTP), Lysergol, Piperlongumine Pongamol & Scopine HCl.
Botanical Extracts :Amla, Bacopa, Banaba,Boswellia, Cascara, Coleus, Fenugreek, Garcinia, Gentian, Green Tea, Green Coffee, Guggul, Gymnema, Horse Chestnut, Licorice, Mucuna, Pelargonium, Senna, Tribulus,Trigonella, Valerian etc. We also specialize in the manufacturing of custom made products on an exclusive basis.
Regulatory Compliance : Facilities inspected and approved by EDQM, KFDA, TGA & USFDA.
CEP for Digoxin & Hyoscine butylbromide, DMF available for almost all products.
ALP Pharm business was started in Dec. 2002. We began to manufacture some APIs in the partners facilities since 2007. Some of our APIs have been approved by EDQM and US FDA. Our products: Bivalirudin, Bromfenac sodium, Calcipotriene anhydrous,Calcipotriene monohydrate,cidofovir, cilostazol, Clopidogrel Bisulfate, Doxercalciferol, D-Methionine, Dronedarone Hydrochloride, Eptifibatide, Lanreotide,Loteprednol Etabanate, Lurasidone Hydrochloride, Mesalamine, Nepafenac, Palonosetron HCl, Paricalcitol, Roflumilast,Silodosin, Tamsulosin, Tranexamic acid, Zoledronic Acid. meet FDA – cGMP and EDQM compliance requirements. Tel: 86-10-56531161,71,81,91; Email: [email protected]; Website: www.alppharm.com
Altergon is a leading Pharmaceutical Company in the biotech production of Ultrapure Hyaluronic Acid (Sodium Hyaluronate Bulk) as well as in the production of Patches (Transdermal - Drug in Adhesive - Hydrogel) and Orodispersible Films. The Manufacturing and Purification of Hyaluronate, together with the formulation and manufacturing of Hydrogel medicated plasters are strong Altergon know how.
The company has a high level formulation and development knowhow, and an extensive regulatory experience in US and EU.
Altergon provides a wide range of services for the pharmaceutical industry on a contract basis: Research and Development services with thorough supervision, management and fulfillment of the project, development of topical formulations and drug delivery technologies (pharma and Medical Device).
Al Wajir Pharmaceuticals LLC is the only company in the
Middle East manufacturing Pharmaceutical Pellets. It has been developed to
manufacture all kinds of pharmaceutical pellets with a current installed capacity
of 20 MT per month. The company has
future expansion plans to 35 MT per month in next 5 years. The facility is GMP certified. Al Wajir Pharmaceuticals LLC has an GMP, Ministry of Health 0f Oman certification. It started its commercial productions in
Amano Enzyme Europe Limited
is a subsidiary of Amano Enzyme Inc. that has been a major producer of enzymes
in Japan for nearly 70 years. We are located in the United Kingdom and supply
customers across Europe with Amano's speciality enzymes for biocatalysis,
digestive aids, anti-inflammatory, diagnostics, food processing and other
industrial use. In addition, we are launching sterile enzymes applicable to
cell/tissue dissociation in tissue reengineering such as breast reconstruction
as well as to infertility treatment. Enzymes are environmentally-friendly
alternatives and Amano Enzyme is committed to contributing to the environment
and the society through our enzymes.
AmbioPharm Inc (API) is a full-service peptide manufacturing company headquartered at our cGMP peptide manufacturing facility in North Augusta, S.C. In our cGMP manufacturing facility in Shanghai, China, we manufacture peptides at very large scales, provide pilot manufacturing and process development, and manufacture raw materials, building blocks, and custom peptides. Our two cGMP facilities are capable of handling any manufacturing scale to produce bulk peptides to custom specifications using a wide-range of skill sets in solid and solution-phase chemistry. In addition to manufacturing peptides, we also perform organic conjugations of peptides to proteins, toxoids, antifungals, KLH, and PEG.
Amoli Organics Pvt. Ltd., India Is a leading pharmaceutical manufacturer and exporter of API's & Intermediates established 25 years ago. Amoli has 2 manufacturing sites approved by WHO GMP, USFDA, EDQM/EU GMP , PMDA(Japan), TGA (Australia), ANVISA(Brazil) and COFEPRIS(Mexico). We offer APIs covering Anti- Inflammatory, Anti-Hyperlipidemic , Anti- Depressant,Anti-Diabetic, Anti-Convulsant , Anti- Fungal & Vitamin API's. Our key products are Diclofenac Salts, Atorvastatin Calcium and Rosuvastatin. Company's R&D center spread over 12000 sq ft. is engaged in developing in-house process technology for APIs. Amoli's APIs have excellent acceptability globally. Amoli has good presence in more than 85 countries including India.
Amphastar Nanjing Pharmaceuticals, Inc., (ANP), located in the Nanjing Economic and Technological Development Zone in Nanjing, Jiangsu Province of China, is an FDA registered manufacturer of active pharmaceutical ingredients (API) and intermediates. The products manufactured at ANP are intended only for use by Amphastar and its wholly owned subsidiaries. This assures that Amphastar maintains traceability and control of its supply chain back to the starting material.
Anlit develops and produces high-quality dietary supplements for the whole family. With product R&D innovation as its hallmark, the company has a complete portfolio of shelf-ready products. Anlit's mission is to make nutritional supplements friendly, easy and comfortable for everyone. Anlit products are consumed daily (and happily) by adults and children in more than 25 countries around the world, including the United States, Europe, Russia, Southeast Asia and South Africa. The company has built its reputation on science-backed innovation, quality and responsiveness to customer requirements. Studies show that kids , but not only, are more likely to take food supplements that are appealing to taste, touch, smell and sight. Anlit's products are designed to address child and adult preferences with its proprietary delivery systems: pectin-based gummies bears and VitaBites chewables. Anlit is continuously innovating and perfecting its products, formulations, technologies and delivery systems, setting industry benchmarks and introducing progressive products to the market.
Anzen Exports is a one stop Pharma Outsourcing Company. It is a merchant export organisation with core competence in Active Pharmaceutical Ingredients, Herbals, Nutraceuticals and Formulations. Our sister concern M/s Anaha Life Care, a Nutraceuticals formulations & Product Development Company offers exclusive range of Nutraceuticals & Nutri Cosmetics. We have been successfully providing our services to approximately 500 companies in over 70 countries around the world, and counting, for the past 26 years. Our group turnover currently is a little over USD 75 million. Our Product range offers a wide variety of the above mentioned items manufactured by reputed manufacturers of India, with whom we have a long term memorandum of understandings. Please visit our website, Anzen (http://www.anzen.co.in) and Anaha (http://www.anahalifecare.com) for any further information.
APIRx Pharmaceuticals B.V. is a leading pharmaceutical company dedicated to manufacturing of natural cannabinoid API's (Active Pharmaceutical Ingredients), which are extracted from cannabis plant material and purified to pharma grade. All manufacturing stages are performed under cGMP conditions. The following cannabinoids are in our product portfolio: Tetrahydrocannabinol (THC or Delta-9THC) Cannabidiol (CBD) Cannabigerol (CBG) APIRx also uses its own API's for the development of new Rx and OTC drugs, nutraceuticals, cosmeceuticals and other products.
Apollo Scientific offers a huge range of organic intermediates (currently over 75,000). In our own UK laboratories we manufacture fluorochemicals and key heterocyclic building blocks in quantities from just a few grams to over 50kg. Many of these compounds are novel and we are regularly supplying interesting new molecules to the pharmaceutical industry from an initial small requirement, through kilo-lab and beyond. Apollo also undertakes custom synthesis work, and has agreements in place with approved third-party toll converters. Therefore if required, quantities over 100Kg of our own manufactured intermediates can be provided using technology transfer of Apollo's procedures.
For over 40 years, Apotex has been a trusted name in the Canadian pharmaceutical community, providing patients with increased access to quality, affordable medicines. A global company, we operate distinct lines of business including Global Generics (with 300+ prescription and OTC drugs in over 4000 doses and formats), Apotex Pharmachem (with 200+ API's developed for major markets), Apobiologix for biosimilars and complex molecule development, and ApoPharma for innovative medicines. Apotex Inc. offers a wide out-licensing portfolio of over 100 finished drug products and 200 active pharmaceutical ingredients (API), backed by a robust development pipeline focused on the top global generic priorities. Apotex Inc. is also interested in licensing pharmaceuticals from drug development/delivery companies who want to grow their business in the US, Canada, Caribbean, EMEA, APAC, and LATAM markets by utilizing our “Best in Class” commercial teams to sell, market and distribute their products. Since our founding, we have been dedicated to maintaining sustainable, state-of-the-art processes – processes that ensure our products meet the highest quality and safety standards in all markets. Through our unwavering commitment to excellence and innovation, we help communities across the world live longer, healthier lives.
We are a Pharmaceutical Company aligned across two business verticals viz. Products and Services. Our Products business comprises manufacture and sales of APIs and Intermediates to innovator and generic pharmaceutical players in both Domestic and International markets including the regulated markets.
Argus Pharmaceuticals Ltd (Argus) is dedicated to development and commercialization of active pharmaceutical ingredients and formulations for domestic and global generic market mainly through the fermentation process. The team and structure of Argus makes it possible to work in a more effective way to give quick response to the necessities of the market and implement development plan and activities in a early stage. The Argus is committed to striving for more chances to improve the quality of life for individuals by introducing high quality and cost effective generic pharmaceutical products.
Arshine Pharmaceutical Co Ltd (Arshine) is a trading company mainly engaged in the export of products including, without limitation, pharmaceutical raw materials both for vet and human, also Vitamins, Amino Acids, minerals, plant extract, feed and food additives. Ever since the establishment of Arshine in 2007, our working staff members have seen a rapid increase from 3 to 25, and we have established close and stable cooperative relationships with over 300 domestic pharmaceutical and chemical enterprises, in most cases of which we are representing our partners as their regional or even exclusive marketing agent. The past 5 years of Arshine's sale have also seen a rapid increase with an average annual increase rate over 25%. In particular, we have a breakthrough record of US$ 20 million for our sale of bulk pharmaceutical chemicals in the year of 2011. Thus far, Arshine's export items exceed 400, more than 10 of which are leading China's exportation directory. We have business in 13 countries and areas covering 4 continents globally and have developed into one of the major pharmaceuticals export enterprises in southern China. Looking forward, Arshine has extended the product lines into all necessary products for pharmaceutical enterprises, e.g., medicine packing material such as plastic bottle, glass bottle, plastic tube, laminated tube, as well as medicine packing machine including powder filling machine, ointment filling and sealing machine, among others.
Arven focuses on difficult to make products.Taking into account the rapidly changing dynamics of global regulatory environment, Arven constructed a dedicated high-tech product manufacturing facility only for inhalation and high technology product manufacturing. As the first company invested in these fields in Turkey, Arven's primary objective is to penetrate into international markets.
LONGCHEM CO., LIMITED (Ash-Longchem, a joint venture between Ash Ingredients and Longchem) specializes in project development and custom manufacturing of various INTERMEDIATES for APIs. We serve our customers with our quick action on inquiries and competitive offers under cost-effective management system, with guarantee of manufacturing and quality control as per GMP. Our modern labs act as firm supports to our focus on project development. Our manufacturing site of 80000sqm is waiting for your site audit. Reliable network of close business partners also extend our arms with more technology advantages. Our ultimate goal is Customer satisfaction.
Aspen is a global supplier of branded and generic pharmaceutical products as well as infant nutritional and consumer healthcare products in selected territories. In line with the Group's commercial, production and territorial strategies, Aspen has identified thrombosis, anaesthetics, high potency & cytotoxics and infant nutritionals as four therapeutic categories which will get the highest focus based on materiality and future potential.The group has an extensive global presence with more than 10,000 employees. Aspen has a strong presence in both emerging and developed countries with more than ???????60 established business operations in approximately 50 countries. The Group supplies medicines and products to more than 150 countries.
Aspen Oss B.V., established in 1923, is a leading global supplier of Active Pharmaceutical Ingredients (APIs) to the global pharmaceutical industry. Aspen Oss specializes in the manufacture of highly complex APIs and is dedicated to the production of high quality APIs. Our customers benefit from our extensive experience by receiving a high level of quality and regulatory support. Our facilities are regularly inspected and approved by international health authorities, such as the US FDA, Dutch Health Authorities and PMDA.
Multinational group dedicated to green chemistry technology with focus on CMO &CRO and process development/optimize for API, pharmaceutical intermediate, electronic chemicals, monomers for functional polymers.
Athena aspires to be a global leader in specialty pharma, innovation and drug delivery. It aspires to be a partner of choice for multinational pharmaceutical companies for their life cycle management requirement for mature products with a mission to enhance value to patients & improve compliance which is critical for treatment.
Aurisco is an innovative company dedicated to developing and manufacturing pharmaceutical chemicals serving pharmaceutical companies worldwide. With 2 manufacturing sites for chemistry synthesis & fermentation, all of which are operated according to cGMP standards, Aurisco offers Active Pharmaceutical ingredients (APIs especially in segments of Steroids, Oncology, Anti-Virus and etc.) and drug intermediates as well as contract developing and manufacturing of pharmaceutical chemicals from kilos to tons.
Auro Laboratories Limited is manufacturing generic API's with corporate office located at Mumbai and the manufacturing facility located at Tarapur, Maharashtra, India. We have Certificate of Suitability(COS) for Metformin Hydrochloride and Chlorphenamine Maleate. Manufacturing facility has EUGMP and WHO-GMP certification.API Products manufactured: Metformin Hydrochloride, Glibenclamide, Glimepiride, Glipizide, Chlorphenamine Maleate, Chlorzoxazone.
AVF Chemical Industrial Co., Ltd is a large holding company, with three production bases and several contract manufacturers. We are specialized in high-tech level Animal health products, including veterinary APIs and Vitamin D3.
Our production is strict to GMPs. With a professional Registry Team, we have obtained ISO Kosher Halal FAMI-QS and the registrations of EMEA and EPA. From developing, sourcing, manufacturing, quality control to delivery, AVF controls every stage with a professional management system to guarantee stable quality and safety and ensure to provide value-added products and services for our partners.
With 10-year experience, our products have been sold to Europe, America, and Asia etc more than 40 countries and region, and we have a good reputation in these fields. And we are looking forward to be with you on the way of development.
We are manufacturer of advance intermediates of Citicholine Capecitabine Luliconazole Imatinib Mesylate Also marketing partner for selling following APIs : Befotiamine Bicalutamide - with CEP Celecoxib Citalopram Hydrobromide Citicholine Sodium Etoricoxib Famotidine Nilutamide Pantoprazole Sodium Quetiapine Fumarate Pazopanib Abiraterone Acetate Bortezomib Busulphan / busulfan Capecitabine Cytarabine Dacarbazine Docetaxel Gefitinib Gemcitabine Imatinib Mesylate Irinotecan HCl Melphalan Paclitaxel Pemetrexed Disodium Heptahydrate Sunitinib Dasatinib Ibrutinib Biperiden HCl Colistimethate Sodium Itraconazole Luliconazole Modafinil Primidone - with CEP Suxamethonium Chloride / Succinyl choline chloride Tropicamide Eberconazole Aprepitant Moxifloxacin HCl Diltiazem HCl Racecadotril Tamsulosin HCl Enoxaparin Sodium L Asparaginase pegylated Asparaginase Liraglutide Roxadustat Oxanimod Netarsudil Mesylate Ozenoxacin Benznidazole L-Glutamine Deutetrabenazine Selexipag Lumacaftor Efinaconazole Luliconazole Azelaic Acid Besifloxacin HCl Carbidopa Carbimazole Chlorthalidone Dapoxetine HCl Docosanol Folic Acid Gabapentin Enacarbil Gemifloxacin Mesylate Ibudilast Ipragliflozin Lomitapide Mesylate Mesalamine / Mesalazine with CEP Methimazole Mirtazapine with CEP Minocycline Nitrofurantoin Ospemifene Raltegravir Potassium Strontium Ranelate Trelagliptin Tigecycline Zonisamide Telmisartan Clopidogrel Bisulphate Memantaine Pregabalin Pre-Filled Syringes of Enoxaparin Sodium 40 mg and 60 mg
About Bayer Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2017, the Group employed around 99,800 people and had sales of EUR 35.0 billion. Capital expenditures amounted to EUR 2.4 billion, R&D expenses to EUR 4.5 billion. For more information, go to www.bayer.com.
BBT is a Contract Service Organization focused on the development, production, manufacturing and international sales of Active Pharmaceutical Ingredients for the health-care, feed-additives and pharmaceutical industry world wide. BBT produces and manufactures (GMP), Streptokinase, Urokinase, HCG, HMG, FSH and Aprotinin. BBT develops and produces (GMP), e.g. Lactobacilli, Streptococci, Enterobacteria, Bifidobacteria and yeast.
BCN Peptides is focused on the GMP manufacture of synthetic peptides API's for pharmaceutical and veterinary application. We manufacture from R&D to commercial quantities of generic peptides and NCE's. Our state of the heart facility is fully GMP, US FDA and EMEA approved.
PJSC SIC “Borshchahivskiy CPP” is innovative pharmaceutical enterprise of European level that successfully combines the scientific potential and high-tech modern production in a single effective complex; manufactures the products under the international quality standards; reliable partner that clearly fulfills the obligations and acts on the principles of mutually advantageous cooperation.
PJSC SIC “Borshchahivskiy CPP” is the first pharmaceutical plant in Ukraine that has fully implemented the European standards in quality (GMP, ISO 9001), distribution (GDP), environmental management (ISO 14001), energy management (ISO 50001), Occupational Health and Safety (OHSAS 18001), and also social accountability (SA 8000).
The company has a balanced product portfolio: medicinal products (more than 100 items), veterinary medications, dietary/food supplements, disinfectants; occupies one of the leading positions in terms of production and sales volumes of finished dosage forms among Ukrainian manufacturers; manufactures the products of different price groups and is socially oriented.
BDR Group of companies has grown steadily and become a
house-hold name in the pharmaceutical Industry over the last 14 years, in both
domestic and international arenas. We are recognised as a “niche” player in
manufacturing of Pharmaceutical APIs and for our renowned new age formulations.
Core strength lies in identification of newer molecules, development and
commercialisation. The group is complemented majorly by its two companies - BDR
Pharmaceuticals International Pvt Ltd and BDR Life sciences Pvt. Ltd, each one
having stamped its own supremacy in respective fields, i.e. API and formulation
BDR Group focuses on development in 4 specialized therapeutic segments, viz. Oncology, Critical care, Gynecology & Neurology, which are its dream segments. BDR‘s philosophy of sustained growth and consolidation is achieved by strategic tie-ups with several globally renowned players
BEC Chemicals specializes in manufacturing API's and Intermediates. We are WHO-GMP, EU-GMP, ISO 9001:2008, 14001:2004, 18001:2007 and OHSAS certified. We are 100% an export-oriented unit. Our manufacturing plant is at Roha (125kms from Mumbai), with dedicated blocks for each product. We manufacture APIs: Ketoprofen, Ketoprofen Lysinate, Dex-Ketoprofen Trometamol, Mesalamine/ Mesalazine. Our pipeline products are Hydroxytetrahydrofuran, Montelukast Sodium, Carbocisteine, Carbocisteine Lysinate. We have a Research and Development Center in Mumbai. BEC also has a state-of-the-art micronization unit at Mahape (near Mumbai).
Beijing Hope Pharmaceutical Co.,Ltd. (stock
number 836438), founded in 2005 and located at Beijing Economic-technological
Development Area, is a state level high-tech enterprise dedicated to the
development, manufacture and promotion of chemical drugs. According to GMP and
related regulations, together with partners, manufacturing sites have been
built in Shandong, Hebei, Anhui, Zhejiang province which have passed the
domestic GMP qualification and customers' audits of European and North American
Beijing HMT Medical Technology Co., Ltd. (HMT) is a wholly owned subsidiary of Hope specialized in R&D, manufacture, sales of Pharmaceutical Intermediates (PIs) and is oriented towards the global market. Depending on many years' experience in drug R&D and registration, we can provide our client not only the high-quality products, but also comprehensive technical and document support to assist them in solving the problems.
Dr.JCR BIO, leading manufacturer and supplier of Pharma reference standards includes Impurities and metabolites. We have a world class research facility to provide contract research (CRO) and custom synthesis (CMO) includes CRAM's at Hyderabad, India.
Beijing Keyifeng (KYF) Biotech Development Co., Ltd.,founded in August 2000, is a high-tech enterprise integrating R&D, production and marketing into whole. The company situated at the industrial area of Tongzhou District, Beijing city, covers an area of 22,000 m2, consists of 1 pilot plant, 3 multipurpose manufacturing plant (2 chem. syn, 1 bio- syn, total capacity up to 80,000 l plus of g.1 and s.s reactors) and 1 power-supply plant, with the support of necessary advanced instruments for QC/QA, microbial and chem. R&D lab. as well as several functional sectors. It owns over 220 staffs among whom 113 are professional, including 10 senior engineers and 16 engineers, leading by well known experts and linking with excellent labor force. It mainly engages in the R&D and production of steroids API and its intermediates. According to market request abroad, leading by R&D and emphasizing in commercialization of novel products and process innovation, now KYF has over twenty products available and has developed into a based on R&D and manufacturing, comprehensive and strength entity. As a US FDA approved and GMP certificated enterprise, KYF's high potency products such as Levonorgestrel, Ethinylestradiol, Tibolone, Gestodene, Estriol, Trenbolone Acetate, Norgestimate, Lynoestrenol, Melengestrol Acetate, Estradiol, etc. have been supplied to Europe, North and South America, Asian-Pacific, Hong Kong, Taiwan and so on more than 20 countries/area. Documents preparation for COS inspection of some products is ongoing. With business essence based on products quality, abiding by enterprise prestige and aiming at both win, KYF will sincerely serve for all domestic and oversea customers.
Bayir is professionally managed company engaged in manufacture & marketing of select active Pharmaceuticals, Nutraceutical and Botanical extracts.(Coleus Forskolin, Glucosamine, Garcinia Extract, Chondroitin sulphate, Herbal Extract, Curcumin). Group's manufacturing units are equipped with modern facilties manned by highly qualified professionals are WHO cGMP certified.
Berko Pharmaceuticals was found as Beran
Laboratory by Ph. Berat Beran who started his career as a pharmacist in 1970s.
In 1984, Berko Pharmaceuticals was found and took place in the pharmaceutical
industry. Berko Pharmaceuticals has contributed to the sector and to Turkish
Medicine with innovative products that are not in the market. Berko
Pharmaceuticals is a company that dedicated itself to improve human health.
Berko Pharmaceuticals, have been aiming to contribute to human health with “For Healthy Tomorrows” vision for more than 30 years and is the fastest growing company with its more than 60 products, about 550 employees and 2 manufacturing plants which has 10 thousand square meters covered area. With its world standart high quality manufacturing facilities, Berko Pharmaceuticals can manufacture 62,3 million boxes with two-shift operation annually. The new investment of Berko Pharmaceuticals in the third manufacturing plant with 11 thousand square meter area is under construction.
Berko Pharmaceuticals, breakthrough in the field of export and works in this area actively continues. Berko Pharmaceuticals, who is exporting and signed export agreements with total of 33 countries from 2015 until this day, aims to export to North America, South America, USA, Russia, Commonwealth of Independent States and Africa. Also, Berko Pharmaceuticals, has has FDA registration for their manufacturing plant as well as approval for ZincOmega Fish Oils which will begin to export to USA soon.
Berko Pharmaceuticals, put emphasis on importance to social responsibility projects, thus, touch life of people with developed projects. Berko Pharmaceuticals, focuses on this topic and completed many projects in recent years. At the beginning of these projects, there is “Berko Çocuk Tiyatrosu”, which was found to contribute society and art, and “Eczac?n?n Kariyer Yolu”, which contributes to career development of students from pharmacy faculty. At the same time, Berko Pharmaceuticals Social Responsibility and Environment Fellowship, which found by Berko Pharmaceuticals' employees with volunteering basis, realizes many projects as well. Among these projects, Berko Pharmaceuticals provided clothes, shoes, toys, books, school and hygiene materials and scholarships to rural schools, oncology patient children, people with disabilities, rehabilitation centers and to society for protection of children. Berko Pharmaceuticals, provides scholarship to 10 primary school students and 20 university students.
With the challenging spirit for the best technology of Biotech, BIFIDO is trying to be the world best in probiotics based food technology.
We focus on basic research and product development using probiotics. Among various probiotics, Bifidobacterium is considered to be the most beneficial microorganism for the maintenance of microbial balance in the intestinal tract. Nowadays Bifidobacterium and other lactic acid bacteria are being applied widely in functional foods. Especially, we are at the leading edge in the development of human-health promoting Bifidobacterium.
We produce raw materials of various probiotics and fermented ginseng by our own technology, and manufacture finished product of ZIGUNUK brand and OEM/ODM products. To extend the application of probiotics into our daily life, we are always trying our best to be the leading edge on probiotics health food area.
BIFODAN develops and manufactures innovative probiotic finished solutions for B2B customers worldwide. Our dedication to probiotics and expertise in research and development of probiotic dietary supplements is the foundation of our YOURBRAND product portfolio, immediately available for private label marketing. YOURBRAND products are based on clinically documented probiotics and are manufactured at our GMP/NSF/FDA inspected factory in Copenhagen, Denmark. Please visit us at CPhI 2018 booth # 14.0C90 or www.BIFODAN.com.
BIOCAD is a vertically integrated biopharmaceutical company which excels at full-cycle drug discovery and development, as well as commercial-scale manufacturing of biological and chemical therapeutics for the treatment of cancer and autoimmune disorders. BIOCAD's advanced MabNext program is focused on the development of monoclonal antibodies without non-human sequences with high specific activity. The company also has several high-quality mAb biosimilars on the world market.
Biochimex has more than 35 years experience in pharmaceutical Ingredient distribution and transformation. We developed strong partnerships with worldwide producers. We support our European and North African customers for new projects (sourcing, regulatory support, validation batch …). We are also specialized in API micronisation and sterilization.
Biofer S.p.A. is an Italian independent Company, specialized in the manufacturing of both APIs and Dosage Forms. Biofer complies to the highest GMP standards, always paying great attention to detail in all quality aspects. Among its Products: Iron Complexes, Heparins/Heparinoids, Steroids, Enzymes, Folinates and Miscellaneous.
BioGrowing is a group company dedicated to the probiotic business, starting with brand probiotic formulations in the China market 20 years ago, and expanded from supplement formulations to dairy, functional foods and agriculture probiotics.
Business Scope: probiotic strains in bulk; probiotic blends/premix; probiotic formulations in bulk; probiotic formulations in private labels; dairy starter cultures; functional foods products; and feed additives and agricuture probiotics.
Here are our products and services:-
For commercial probiotic products
Bulk probiotic strains (Lactic Acid Bacteria)
Probiotic supplements in capsules, sachets/strips, powder formulations.
Dairy starter cultures for yoghurt, yoghurt drink, sour cream, soft cheese, cottage cheese etc.
Food probiotic programs, include bakery, drinks, dairy products
Animal nutrition probiotics, feed additives and starter cultures, agriculture probiotics
For market services
Bionovax, an API manufacturer with GMP plant, produces Heparin Sodium, Heparin Lithium & LMW Heparin (Enoxaparin) in compliance with TFDA, FDA, EP, and PMDA. Heparinoid is also available for device and cosmetic purposes. Collaborator/broker companies in synergy to develop final dosage forms using our consistent high quality APIs are also welcome.